Cytek Biosciences, Inc. (CTKB) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 379.3M | 392M | 388.49M | 382.82M | 380.5M | 396.45M | 390.19M | 384.08M | 388.65M | 392.06M | 422.31M | 424.82M |
| Cash & Short-Term Investments | 262.23M | 261.53M | 261.73M | 262.02M | 265.61M | 277.86M | 277.78M | 277.21M | 270.09M | 262.41M | 288.02M | 298.84M |
| Cash Only | 65.67M | 90.85M | 93.28M | 75.47M | 95.3M | 98.72M | 162.27M | 177.89M | 168.79M | 167.3M | 163.63M | 131.54M |
| Short-Term Investments | 196.56M | 170.68M | 168.45M | 186.55M | 170.31M | 179.15M | 115.5M | 99.32M | 101.3M | 95.11M | 124.39M | 167.29M |
| Accounts Receivable | 56.48M | 72.13M | 61.67M | 56.67M | 55.21M | 60.59M | 52.63M | 44.75M | 50.37M | 56.12M | 57.63M | 52.1M |
| Days Sales Outstanding | 131.13 | 99.05 | 104.1 | 111.62 | 125.69 | 90.62 | 86.99 | 92.84 | 108.01 | 89.86 | 105.16 | 89.01 |
| Inventory | 49.79M | 48.43M | 51.65M | 49.49M | 45.35M | 43.89M | 46.8M | 50.07M | 54.74M | 60.88M | 66.88M | 65.73M |
| Days Inventory Outstanding | 193.17 | 157.35 | 188.03 | 198.53 | 188.54 | 175.11 | 198.09 | 225.15 | 240.8 | 233.34 | 292.95 | 285.78 |
| Other Current Assets | 3.6M | 2.98M | 2.92M | 2.76M | 2.29M | 1.97M | 12.98M | 1.94M | 2.84M | 2.56M | 2.25M | 2.11M |
| Total Non-Current Assets | 69.81M | 69.55M | 106.43M | 110.5M | 102.09M | 103.05M | 101.03M | 99.64M | 103.42M | 102.4M | 97.11M | 100.23M |
| Property, Plant & Equipment | 31.11M | 29.32M | 29.2M | 34.74M | 27.7M | 28.13M | 28.63M | 27.44M | 28.2M | 29.26M | 29.12M | 28.01M |
| Fixed Asset Turnover | 1.46x | 2.12x | 1.64x | 1.46x | 1.49x | 2.03x | 1.84x | 1.68x | 1.56x | 2.00x | 1.68x | 1.75x |
| Goodwill | 16.69M | 16.7M | 16.7M | 16.71M | 16.68M | 16.66M | 16.18M | 16.18M | 16.18M | 16.18M | 16.46M | 19.14M |
| Intangible Assets | 15.7M | 16.82M | 17.68M | 18.6M | 19.43M | 20.13M | 20.49M | 21.42M | 22.25M | 23.08M | 24.29M | 23.68M |
| Long-Term Investments | 1.6M | 0 | 1.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4.71M | 6.7M | 2.86M | 4.68M | 4.57M | 4.76M | 4.95M | 4.92M | 4.08M | 3.38M | 3.17M | 3.01M |
| Total Assets | 449.11M | 461.54M | 494.92M | 493.32M | 482.6M | 499.5M | 491.23M | 483.73M | 492.07M | 494.46M | 519.43M | 525.05M |
| Asset Turnover | 0.10x | 0.13x | 0.11x | 0.09x | 0.08x | 0.12x | 0.11x | 0.10x | 0.09x | 0.11x | 0.09x | 0.09x |
| Asset Growth % | -6.94% | -7.6% | 0.75% | 1.98% | -1.92% | 1.02% | -5.43% | -7.87% | -6.2% | -4.82% | 4.03% | 6.54% |
| Total Current Liabilities | 80.94M | 77.8M | 75.21M | 73.27M | 67.69M | 67.66M | 62.8M | 52.38M | 55.57M | 56.23M | 58.69M | 53.59M |
| Accounts Payable | 6.74M | 6.41M | 7.63M | 6.85M | 6.25M | 5.53M | 5.39M | 3.19M | 3.73M | 3.03M | 4.71M | 3.08M |
| Days Payables Outstanding | 25.86 | 22.08 | 26.93 | 27.42 | 24.88 | 21.08 | 17.55 | 14.86 | 14.07 | 14.14 | 17.22 | 17.67 |
| Short-Term Debt | 15.86M | 6.3M | 12.85M | 5.44M | 3.99M | 4.66M | 0 | 1.93M | 1.94M | 565K | 548K | 551K |
| Deferred Revenue (Current) | 30.03M | 29.57M | 28.74M | 30.01M | 28.75M | 26.61M | 25.36M | 25.04M | 24.68M | 24.13M | 24.69M | 22.15M |
| Other Current Liabilities | 16.43M | 18.14M | 11.35M | 16.12M | 12.75M | 16.87M | 32.04M | 13.15M | 14.75M | 16.7M | 16.83M | 15.34M |
| Current Ratio | 4.69x | 5.04x | 5.17x | 5.22x | 5.62x | 5.86x | 6.21x | 7.33x | 6.99x | 6.97x | 7.20x | 7.93x |
| Quick Ratio | 4.07x | 4.42x | 4.48x | 4.55x | 4.95x | 5.21x | 5.47x | 6.38x | 6.01x | 5.89x | 6.06x | 6.70x |
| Cash Conversion Cycle | 298.43 | 234.32 | 265.2 | 282.73 | 289.35 | 244.65 | 267.53 | 303.14 | 334.73 | 309.05 | 380.9 | 357.12 |
| Total Non-Current Liabilities | 40.53M | 42M | 41.14M | 42.49M | 35.28M | 36.1M | 42.97M | 42.22M | 43.89M | 45.17M | 45.21M | 47.28M |
| Long-Term Debt | 7.02M | 525K | 8.81M | 791K | 918K | 1.05M | 1.24M | 1.33M | 1.48M | 1.65M | 1.74M | 1.88M |
| Capital Lease Obligations | 13.44M | 14.04M | 13.49M | 14.12M | 7.45M | 7.55M | 7.76M | 8.11M | 8.7M | 9.48M | 10.14M | 10.83M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.4M | 9.09M | 2.52M | 10.96M | 11.2M | 11.4M | 19.19M | 18.72M | 18.55M | 18.91M | 18.38M | 18.52M |
| Total Liabilities | 121.47M | 119.8M | 116.35M | 115.76M | 102.97M | 103.76M | 105.76M | 94.6M | 99.45M | 101.39M | 103.91M | 100.88M |
| Total Debt | 36.33M | 23.74M | 35.16M | 23.68M | 15.9M | 17.02M | 8.99M | 13.78M | 14.39M | 14.14M | 15.3M | 16.21M |
| Net Debt | -29.34M | -67.11M | -58.12M | -51.79M | -79.4M | -81.7M | -153.28M | -164.11M | -154.4M | -153.16M | -148.33M | -115.34M |
| Debt / Equity | 0.11x | 0.07x | 0.09x | 0.06x | 0.04x | 0.04x | 0.02x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x |
| Debt / EBITDA | - | - | - | - | - | 2.97x | - | - | - | 6.18x | - | - |
| Net Debt / EBITDA | - | - | - | - | - | -14.27x | - | - | - | -66.94x | - | - |
| Interest Coverage | -70.47x | -4.56x | -14.73x | -15.36x | -37.71x | - | 2.32x | -52.63x | -19.39x | 11.43x | -6.03x | -15.12x |
| Total Equity | 327.64M | 341.74M | 378.57M | 377.56M | 379.62M | 395.74M | 385.46M | 389.12M | 392.61M | 393.06M | 415.52M | 424.18M |
| Equity Growth % | -13.69% | -13.64% | -1.79% | -2.97% | -3.31% | 0.68% | -7.23% | -8.26% | -7.28% | -7.63% | -0.24% | 3.17% |
| Book Value per Share | 2.55 | 2.67 | 2.97 | 2.97 | 2.96 | 3.06 | 2.90 | 2.96 | 3.00 | 3.01 | 3.05 | 3.12 |
| Total Shareholders' Equity | 327.64M | 341.74M | 378.57M | 377.56M | 379.62M | 395.74M | 385.46M | 389.12M | 392.61M | 393.06M | 415.52M | 424.18M |
| Common Stock | 129K | 129K | 128K | 127K | 128K | 129K | 130K | 132K | 131K | 131K | 136K | 136K |
| Retained Earnings | -120.6M | -101.74M | -57.66M | -52.18M | -46.6M | -35.2M | -44.84M | -45.78M | -35.35M | -29.18M | -34.68M | -28.23M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 2.37M | 2.24M | 821K | -38K | -609K | 16K | 101K | -195K | -1.55M | -1.27M | -1.58M | -1.76M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |